Yasir B. Al-Wakeel Insider Trading $NTGN Neon Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Yasir B. Al-Wakeel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Yasir B. Al-Wakeel. Yasir B. Al-Wakeel is CFO and Head of Corp Dev in MERRIMACK PHARMACEUTICALS INC ($MACK) and Chief Financial Officer in Neon Therapeutics, Inc. ($NTGN) and Chief Financial Officer in Kronos Bio, Inc. ($KRON).
Yasir B. Al-Wakeel in Neon Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Yasir B. Al-Wakeel: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: May 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Yasir B. Al-Wakeel in Neon Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, KRON, MACK, NTGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Option Exercise | D | 6.13 | 100,000 | 613,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Option Exercise | D | 10.20 | 61,031 | 622,516 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Option Exercise | D | 5.80 | 192,759 | 1,118,002 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Sell | D | 0.00 | 196,965 | 0 | 0 | 197 K to 0 (-100.00 %) |
| Mar 02 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Payment of Exercise | F | 1.50 | 4,891 | 7,337 | 196,965 | 201.9 K to 197 K (-2.42 %) |
| Feb 27 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Payment of Exercise | F | 1.51 | 5,385 | 8,131 | 201,856 | 207.2 K to 201.9 K (-2.60 %) |
| Jan 13 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Grant | A | 0.00 | 65,000 | 0 | 207,241 | 142.2 K to 207.2 K (+45.70 %) |
| Nov 25 2019 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Grant | A | 0.00 | 75,000 | 0 | 142,241 | 67.2 K to 142.2 K (+111.54 %) |
| Mar 01 2019 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Option Exercise | A | 6.13 | 100,000 | 613,000 | 100,000 | |
| Mar 01 2019 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Grant | A | 0.00 | 50,000 | 0 | 67,241 | 17.2 K to 67.2 K (+290.01 %) |
| Jul 18 2018 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Option Exercise | M | 5.80 | 17,241 | 99,998 | 192,759 | |
| Jul 18 2018 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Buy | M | 5.80 | 17,241 | 99,998 | 17,241 | 0 to 17.2 K |
Page: 1